Reconnect & Rediscover Agenda - Day 3 - NAPNAP

Reconnect & Rediscover Agenda – Day 3

Back to main agenda page

Monday, Oct. 4, 2021

10:15 – 11:15 a.m. (1.0 contact hour)

General 301:  Child & Adolescent Health: In the Know 2021
Beth N. Bolick, DNP, PPCNP-BC, CPNP-AC, FAAN and Karin Reuter-Rice, PhD, CPNP-AC, FCCM, FAAN
The speakers will review selected current affairs in education, policy, and science and evidence-based practice presenting opportunities for participants to be influencers to effect change.

11:30 a.m. – 12:30 p.m. (1.0 contact hour)

General 302: We All Have a Story to Tell: Advocacy is Education
Kristin Gigli, PhD, RN, CPNP-AC, CCRN
Pediatric health priorities often take a backseat to other policies deemed to be more pressing. As a result, there is tremendous opportunity for engagement with national, state, and local policymakers to elevate the awareness of policies that impact pediatric health outcomes and our professional practice. This session will illustrate strategies for engaging in advocacy for our profession and our patients using the latest data on the pediatric-focused APRN workforce and timely, policy-relevant pediatric health priorities. Additionally, the COVID-19 pandemic significantly altered the traditional advocacy experience, resulting in new approaches to advocacy and activism that will be highlighted in the presentation. By the end of this session, attendees will have exposure to strategies focused on the use of education as an advocacy tool to address pediatric health policy priorities, increasing the effectiveness of advocacy efforts.          

1–2:15 p.m. (1.25 contact hours) Concurrent Sessions – Select Only One

  • 303: Is the COVID Vaccine Safe for My Child? Tips to Help Hesitant Parents
    Dana DeShon, DNP, APRN, CPNP-PC
    COVID vaccine was approved for EUA for children aged 12-15 years on May 10, 2021 and social media flooded with questions about the safety in giving it to children. This session will review the most common issues such as safety in development and trial of the current EUA COVID-19 vaccines, fertility concerns, DNA involvement, microchip and natural versus vaccine immunity. Steps to fully vaccinate all children once approved for EUA will be reviewed. You will be prepared in having a conversation with parents to confidently provide factual information and dispelling myths associated with the COVID-19 vaccine.
    Sponsored by: Immunization SIG 
  • 305: Teen Relationships: The Good, The Bad, and The Ugly
    Ashley D. Marass, DNP, CPNP
    This session will discuss teen intimate relationships. From healthy relationships to intimate partner violence and sexual assault, learn the warning signs, how to discuss it and what to do to help them.
    Sponsored by: Adolescent Health SIG

2:30–3:45 p.m. (1.25 contact hours) Concurrent Sessions – Select Only One

  • 306: MIS-C and Other Complications of COVID-19 in Children
    Elizabeth M. Brothers, CPNP-AC
    This presentation will include a discussion of current literature, treatment modalities and complications for active COVID-19 and multisystem inflammatory response syndrome in children both inpatient and outpatient.
    Sponsored by: Acute Care SIG
  • 307: Common Pediatric Emergencies Presenting in Primary Care
    Tresa E. Zielinski, DNP, RN, APN-NP, CPNP-PC
    More information coming soon!
  • 308: Updates in Asthma Management: an Examination of the 2021 GINA Guidelines and 2020 NHLBI Guidelines
    Sarah A.K. Heinonen, DNP, APRN, CPNP and Amanda Filippelli, MSN, MPH, APRN, PPCNP-BC, AE-C
    This session will focus on the pediatric portion of guidelines for the most common chronic lung disease worldwide, Asthma. The first speaker will cover what’s new with the GINA Guidelines for 2021 to include recommendations related to COVID-19 as well as review some of the landmark changes from 2019 GINA updates. The second speaker will review the long awaited 2020 Focused Updates to the Asthma Management Guidelines from the NHLBI.
    Sponsored by: Asthma and Allergy SIG 
Powered by

Website design and development by, Inc.